This report aims to provide a comprehensive presentation of the global market for Obesity Treatment, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treatment.

The Obesity Treatment market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Obesity Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obesity Treatment manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Obesity Treatment market size in 2022 is 11630.00 million US dollars, and it is expected to be 33468.61 million US dollars by 2029, with a compound annual growth rate of 16.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Obesity Treatment market include VIVUS Inc. (US), Arena Pharmaceuticals Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), and Allergan Plc (US). The share of the top 3 players in the Obesity Treatment market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Obesity Treatment market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Adjusting gastric Banding accounted for XX% of Obesity Treatment market in 2022. Roux-en-Y Gastric Bypass share of XX%.
Appetite suppressants accounted for XX% of the Obesity Treatment market in 2022. Combination drugs accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapter 2: Analyzes the Obesity Treatment manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.
Chapters 3-8: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Obesity Treatment market type, application and country market segmentation data.
Chapters 9-10: Segmented the global Obesity Treatment market by type, and application. Analyze the revenue, sales and price of market segments from different perspectives.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 12: Analyzes the Obesity Treatment industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: Analyzes the main companies in the Obesity Treatment industry, including their main businesses, products/services, sales, prices, revenue and gross margin.
Chapter 14: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Latin America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
VIVUS Inc. (US)
Arena Pharmaceuticals Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Novo Nordisk A/S (Denmark)
Allergan Plc (US)
Medtronic (US)
Ethicon (a subsidiary of Johnson & Johnson) (US)
Cousin Biotech (France)
EnteroMedics Inc. (US)
and USGI Medical Inc. (US).

Types list
Adjusting gastric Banding
Roux-en-Y Gastric Bypass
Sleeve gastrectomy
Biliopancreatic diversion with Duodenal Switch
Endoscopic Procedures

Application list
Appetite suppressants
Combination drugs
Malabsorption
Satiety drugs

Table of Content

1 Obesity Treatment Market Introduction and Overview
1.1 Obesity Treatment Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Obesity Treatment Manufacturing Cost Analysis
2.1 Obesity Treatment Key Raw Materials Analysis
2.1.1 Key Raw Materials
2.1.2 Price Trend of Key Raw Materials
2.1.3 Key Suppliers of Raw Materials
2.2 Proportion of Manufacturing Cost Structure
2.2.1 Raw Materials
2.2.2 Labor Cost
2.2.3 Manufacturing Expenses
2.3 Manufacturing Process Analysis of Obesity Treatment
2.4 Obesity Treatment Industrial Chain Analysis
3 Global Market Growth Trends Analysis
3.1 Global Obesity Treatment Market Size & Forecast (2018-2029)
3.2 Obesity Treatment Growth Trends Analysis by Regions
3.2.1 Obesity Treatment Market Size by Regions: 2018 VS 2023 VS 2029
3.2.2 Obesity Treatment Historic Market Size by Regions (2018-2023)
3.2.3 Obesity Treatment Forecasted Market Size by Regions (2023-2029)
3.2.4 North America Obesity Treatment Market Size & Forecast (2018-2029)
3.2.5 Europe Obesity Treatment Market Size & Forecast (2018-2029)
3.2.6 Asia-Pacific Obesity Treatment Market Size & Forecast (2018-2029)
3.2.7 Latin America Obesity Treatment Market Size & Forecast (2018-2029)
3.2.8 Middle East & Africa Obesity Treatment Market Size & Forecast (2018-2029)
4 North America
4.1 North America Obesity Treatment Revenue by Countries
4.1.1 North America Obesity Treatment Revenue by Countries (2018-2029)
4.1.2 North America Obesity Treatment Sales by Countries (2018-2029)
4.2 North America Obesity Treatment Revenue by Players
4.3 North America Obesity Treatment Sales by Types
4.4 North America Obesity Treatment Sales by Applications
4.5 United States
4.6 Canada
5 Asia Pacific
5.1 Asia Pacific Obesity Treatment Revenue by Countries
5.1.1 Asia Pacific Obesity Treatment Revenue by Countries (2018-2029)
5.1.2 Asia Pacific Obesity Treatment Sales by Countries (2018-2029)
5.2 Asia Pacific Obesity Treatment Revenue by Players
5.3 Asia Pacific Obesity Treatment Sales by Types
5.4 Asia Pacific Obesity Treatment Sales by Applications
5.5 China
5.6 Japan
5.7 Korea
5.8 Southeast Asia
5.9 India
5.10 Australia
6 Europe
6.1 Europe Obesity Treatment Revenue by Countries
6.1.1 Europe Obesity Treatment Revenue by Countries (2018-2029)
6.1.2 Europe Obesity Treatment Sales by Countries (2018-2029)
6.2 Europe Obesity Treatment Revenue by Players
6.3 Europe Obesity Treatment Sales by Types
6.4 Europe Obesity Treatment Sales by Applications
6.5 Germany
6.6 France
6.7 UK
6.8 Italy
6.9 Russia
6.10 Spain
6.11 Nordic
7 Latin America
7.1 Latin America Obesity Treatment Revenue by Countries
7.1.1 Latin America Obesity Treatment Revenue by Countries (2018-2029)
7.1.2 Latin America Obesity Treatment Sales by Countries (2018-2029)
7.2 Latin America Obesity Treatment Revenue by Players
7.3 Latin America Obesity Treatment Sales by Types
7.4 Latin America Obesity Treatment Sales by Applications
7.5 Brazil
7.6 Argentina
7.7 Colombia
7.8 Mexico
8 Middle East & Africa
8.1 Middle East & Africa Obesity Treatment Revenue by Countries
8.1.1 Middle East & Africa Obesity Treatment Revenue by Countries (2018-2029)
8.1.2 Middle East & Africa Obesity Treatment Sales by Countries (2018-2029)
8.2 Middle East & Africa Obesity Treatment Revenue by Players
8.3 Middle East & Africa Obesity Treatment Sales by Types
8.4 Middle East & Africa Obesity Treatment Sales by Applications
8.5 Egypt
8.6 South Africa
8.7 Israel
8.8 Turkey
8.9 GCC Countries
9 Global Obesity Treatment Historical and Forecast Market Analysis by Type
9.1 Global Obesity Treatment Revenue and Market Share by Type
9.2 Global Obesity Treatment Sales and Market Share by Type
9.3 Global Obesity Treatment Revenue Market Forecast by Type (2023-2029)
9.4 Global Obesity Treatment Sales Market Forecast by Type (2023-2029)
10 Global Obesity Treatment Historical and Forecast Market Analysis by Application
10.1 Global Obesity Treatment Revenue Market Share by Application (2018-2023)
10.2 Global Obesity Treatment Sales Market Share by Application (2018-2023)
10.3 Obesity Treatment Revenue Market Forecast by Application (2023-2029)
10.4 Obesity Treatment Sales Market Forecast by Application (2023-2029)
11 Obesity Treatment Industry Dynamic Analysis
11.1 Obesity Treatment Market Trends Analysis
11.2 Obesity Treatment Market Drivers Analysis
11.3 Obesity Treatment Market Challenges Analysis
11.4 Obesity Treatment Market Restraints Analysis
11.5 Obesity Treatment Industry Mergers & Acquisitions
11.6 Obesity Treatment Industry New Entrants and Expansion Plans
12 Market Channel, Distributors, Traders and Dealers
12.1 Market Channel Status
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Obesity Treatment Typical Distributors
12.3 Obesity Treatment Typical Customers
13 Players Profiles13.1 VIVUS Inc. (US)
13.1.1 VIVUS Inc. (US) Company Profile
13.1.2 Obesity Treatment Product Overview
13.1.3 VIVUS Inc. (US) Obesity Treatment Market Performance (2018-2023)
13.1.4 VIVUS Inc. (US) Business Overview
13.2 Arena Pharmaceuticals Inc. (US)
13.2.1 Arena Pharmaceuticals Inc. (US) Company Profile
13.2.2 Obesity Treatment Product Overview
13.2.3 Arena Pharmaceuticals Inc. (US) Obesity Treatment Market Performance (2018-2023)
13.2.4 Arena Pharmaceuticals Inc. (US) Business Overview
13.3 F. Hoffmann-La Roche Ltd. (Switzerland)
13.3.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
13.3.2 Obesity Treatment Product Overview
13.3.3 F. Hoffmann-La Roche Ltd. (Switzerland) Obesity Treatment Market Performance (2018-2023)
13.3.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
13.4 Novo Nordisk A/S (Denmark)
13.4.1 Novo Nordisk A/S (Denmark) Company Profile
13.4.2 Obesity Treatment Product Overview
13.4.3 Novo Nordisk A/S (Denmark) Obesity Treatment Market Performance (2018-2023)
13.4.4 Novo Nordisk A/S (Denmark) Business Overview
13.5 Allergan Plc (US)
13.5.1 Allergan Plc (US) Company Profile
13.5.2 Obesity Treatment Product Overview
13.5.3 Allergan Plc (US) Obesity Treatment Market Performance (2018-2023)
13.5.4 Allergan Plc (US) Business Overview
13.6 Medtronic (US)
13.6.1 Medtronic (US) Company Profile
13.6.2 Obesity Treatment Product Overview
13.6.3 Medtronic (US) Obesity Treatment Market Performance (2018-2023)
13.6.4 Medtronic (US) Business Overview
13.7 Ethicon (a subsidiary of Johnson & Johnson) (US)
13.7.1 Ethicon (a subsidiary of Johnson & Johnson) (US) Company Profile
13.7.2 Obesity Treatment Product Overview
13.7.3 Ethicon (a subsidiary of Johnson & Johnson) (US) Obesity Treatment Market Performance (2018-2023)
13.7.4 Ethicon (a subsidiary of Johnson & Johnson) (US) Business Overview
13.8 Cousin Biotech (France)
13.8.1 Cousin Biotech (France) Company Profile
13.8.2 Obesity Treatment Product Overview
13.8.3 Cousin Biotech (France) Obesity Treatment Market Performance (2018-2023)
13.8.4 Cousin Biotech (France) Business Overview
13.9 EnteroMedics Inc. (US)
13.9.1 EnteroMedics Inc. (US) Company Profile
13.9.2 Obesity Treatment Product Overview
13.9.3 EnteroMedics Inc. (US) Obesity Treatment Market Performance (2018-2023)
13.9.4 EnteroMedics Inc. (US) Business Overview
13.10 and USGI Medical Inc. (US).
13.10.1 and USGI Medical Inc. (US). Company Profile
13.10.2 Obesity Treatment Product Overview
13.10.3 and USGI Medical Inc. (US). Obesity Treatment Market Performance (2018-2023)
13.10.4 and USGI Medical Inc. (US). Business Overview
14 Research Findings and Conclusion

List of Tables and Figures

Figure Obesity Treatment Picture
Table Product Definition of Obesity Treatment
Table Global Obesity Treatment Market Size by Type (2023 VS 2029)
Table Global Obesity Treatment Market Size by Application (2023 VS 2029)
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Table Raw Materials Analysis
Table Labor Cost Analysis
Table Manufacturing Expenses Analysis
Figure Manufacturing Process Analysis of Obesity Treatment
Figure Obesity Treatment Industrial Chain Analysis
Figure Global Obesity Treatment Revenue Market Size & Forecast (2018-2029)
Figure Global Obesity Treatment Sales Market Size & Forecast (2018-2029)
Table Obesity Treatment Market Size by Regions: 2018 VS 2023 VS 2029
Table Obesity Treatment Historic Revenue Market Size by Regions (2018-2023)
Table Obesity Treatment Historic Revenue Market Share by Regions (2018-2023)
Table Obesity Treatment Historic Sales Market Size by Regions (2018-2023)
Table Obesity Treatment Historic Sales Market Share by Regions (2018-2023)
Table Obesity Treatment Forecasted Revenue Market Size by Regions (2023-2029)
Table Obesity Treatment Forecasted Revenue Market Share by Regions (2023-2029)
Table Obesity Treatment Forecasted Sales Market Size by Regions (2023-2029)
Table Obesity Treatment Forecasted Sales Market Share by Regions (2023-2029)
Figure North America Obesity Treatment Market Size & Forecast (2018-2029)
Figure Europe Obesity Treatment Market Size & Forecast (2018-2029)
Figure Asia-Pacific Obesity Treatment Market Size & Forecast (2018-2029)
Figure Latin America Obesity Treatment Market Size & Forecast (2018-2029)
Figure Middle East & Africa Obesity Treatment Market Size & Forecast (2018-2029)
Table North America Obesity Treatment Revenue by Countries (2018-2029)
Table North America Obesity Treatment Revenue Market Share by Countries (2018-2029)
Table North America Obesity Treatment Sales by Countries (2018-2029)
Table North America Obesity Treatment Sales Market Share by Countries (2018-2029)
Table North America Obesity Treatment Revenue Share by Players 2022
Table North America Obesity Treatment Sales by Types (2018-2023)
Table North America Obesity Treatment Sales Market Share by Types (2018-2023)
Table North America Obesity Treatment Sales by Applications (2018-2023)
Table North America Obesity Treatment Sales Market Share by Applications (2018-2023)
Figure United States Obesity Treatment Revenue and Growth (2018-2029)
Figure United States Obesity Treatment Sales and Growth (2018-2029)
Figure Canada Obesity Treatment Revenue and Growth (2018-2029)
Figure Canada Obesity Treatment Sales and Growth (2018-2029)
Table Asia-Pacific Obesity Treatment Revenue by Countries (2018-2029)
Table Asia-Pacific Obesity Treatment Revenue Market Share by Countries (2018-2029)
Table Asia-Pacific Obesity Treatment Sales by Countries (2018-2029)
Table Asia-Pacific Obesity Treatment Revenue Market Share by Countries (2018-2029)
Table Asia Pacific Obesity Treatment Revenue Share by Players 2022
Table Asia Pacific Obesity Treatment Sales by Types (2018-2023)
Table Asia Pacific Obesity Treatment Sales Market Share by Types (2018-2023)
Table Asia Pacific Obesity Treatment Sales by Applications (2018-2023)
Table Asia Pacific Obesity Treatment Sales Market Share by Applications (2018-2023)
Figure China Obesity Treatment Revenue and Growth (2018-2029)
Figure China Obesity Treatment Sales and Growth (2018-2029)
Figure Japan Obesity Treatment Revenue and Growth (2018-2029)
Figure Japan Obesity Treatment Sales and Growth (2018-2029)
Figure Korea Obesity Treatment Revenue and Growth (2018-2029)
Figure Korea Obesity Treatment Sales and Growth (2018-2029)
Figure Southeast Asia Obesity Treatment Revenue and Growth (2018-2029)
Figure Southeast Asia Obesity Treatment Sales and Growth (2018-2029)
Figure India Obesity Treatment Revenue and Growth (2018-2029)
Figure India Obesity Treatment Sales and Growth (2018-2029)
Figure Australia Obesity Treatment Revenue and Growth (2018-2029)
Figure Australia Obesity Treatment Sales and Growth (2018-2029)
Table Europe Obesity Treatment Revenue by Countries (2018-2029)
Table Europe Obesity Treatment Revenue Market Share by Countries (2018-2029)
Table Europe Obesity Treatment Sales by Countries (2018-2029)
Table Europe Obesity Treatment Sales Market Share by Countries (2018-2029)
Table Europe Obesity Treatment Revenue Share by Players 2022
Table Europe Obesity Treatment Sales by Types (2018-2023)
Table Europe Obesity Treatment Sales Market Share by Types (2018-2023)
Table Europe Obesity Treatment Sales by Applications (2018-2023)
Table Europe Obesity Treatment Sales Market Share by Applications (2018-2023)
Figure Germany Obesity Treatment Revenue and Growth (2018-2029)
Figure Germany Obesity Treatment Sales and Growth (2018-2029)
Figure France Obesity Treatment Revenue and Growth (2018-2029)
Figure France Obesity Treatment Sales and Growth (2018-2029)
Figure UK Obesity Treatment Revenue and Growth (2018-2029)
Figure UK Obesity Treatment Sales and Growth (2018-2029)
Figure Italy Obesity Treatment Revenue and Growth (2018-2029)
Figure Italy Obesity Treatment Sales and Growth (2018-2029)
Figure Russia Obesity Treatment Revenue and Growth (2018-2029)
Figure Russia Obesity Treatment Sales and Growth (2018-2029)
Figure Spain Obesity Treatment Revenue and Growth (2018-2029)
Figure Spain Obesity Treatment Sales and Growth (2018-2029)
Figure Nordic Obesity Treatment Revenue and Growth (2018-2029)
Figure Nordic Obesity Treatment Sales and Growth (2018-2029)
Table Latin America Obesity Treatment Revenue by Countries (2018-2029)
Table Latin America Obesity Treatment Revenue Market Share by Countries (2018-2029)
Table Latin America Obesity Treatment Sales by Countries (2018-2029)
Table Latin America Obesity Treatment Sales Market Share by Countries (2018-2029)
Table Latin America Obesity Treatment Revenue Share by Players 2022
Table Latin America Obesity Treatment Sales by Types (2018-2023)
Table Latin America Obesity Treatment Sales Market Share by Types (2018-2023)
Table Latin America Obesity Treatment Sales by Applications (2018-2023)
Table Latin America Obesity Treatment Sales Market Share by Applications (2018-2023)
Figure Brazil Obesity Treatment Revenue and Growth (2018-2029)
Figure Brazil Obesity Treatment Sales and Growth (2018-2029)
Figure Argentina Obesity Treatment Revenue and Growth (2018-2029)
Figure Argentina Obesity Treatment Sales and Growth (2018-2029)
Figure Colombia Obesity Treatment Revenue and Growth (2018-2029)
Figure Colombia Obesity Treatment Sales and Growth (2018-2029)
Figure Mexico Obesity Treatment Revenue and Growth (2018-2029)
Figure Mexico Obesity Treatment Sales and Growth (2018-2029)
Table Middle East & Africa Obesity Treatment Revenue by Countries (2018-2029)
Table Middle East & Africa Obesity Treatment Revenue Market Share by Countries (2018-2029)
Table Middle East & Africa Obesity Treatment Sales by Countries (2018-2029)
Table Middle East & Africa Obesity Treatment Sales Market Share by Countries (2018-2029)
Table Latin America Obesity Treatment Revenue Share by Players 2022
Table Middle East & Africa Obesity Treatment Sales by Types (2018-2023)
Table Middle East & Africa Obesity Treatment Sales Market Share by Types (2018-2023)
Table Middle East & Africa Obesity Treatment Sales by Applications (2018-2023)
Table Middle East & Africa Obesity Treatment Sales Market Share by Applications (2018-2023)
Figure Egypt Obesity Treatment Revenue and Growth (2018-2029)
Figure Egypt Obesity Treatment Sales and Growth (2018-2029)
Figure South Africa Obesity Treatment Revenue and Growth (2018-2029)
Figure South Africa Obesity Treatment Sales and Growth (2018-2029)
Figure Israel Obesity Treatment Revenue and Growth (2018-2029)
Figure Israel Obesity Treatment Sales and Growth (2018-2029)
Figure Turkey Obesity Treatment Revenue and Growth (2018-2029)
Figure Turkey Obesity Treatment Sales and Growth (2018-2029)
Figure GCC Countries Obesity Treatment Revenue and Growth (2018-2029)
Figure GCC Countries Obesity Treatment Sales and Growth (2018-2029)
Table Global Obesity Treatment Revenue and Market Size by Type (2018-2023)
Table Global Obesity Treatment Revenue and Market Share by Type (2018-2023)
Table Global Obesity Treatment Sales and Market Size by Type (2018-2023)
Table Global Obesity Treatment Sales and Market Share by Type (2018-2023)
Table Global Obesity Treatment Revenue Market Size Forecast by Type (2023-2029)
Table Global Obesity Treatment Revenue Market Share Forecast by Type (2023-2029)
Table Global Obesity Treatment Sales Market Size Forecast by Type (2023-2029)
Table Global Obesity Treatment Sales Market Share Forecast by Type (2023-2029)
Figure Global Obesity Treatment Market Size and Growth by {Type 1} (2018-2029)
Figure Global Obesity Treatment Market Size and Growth by {Type 2} (2018-2029)
Table Global Obesity Treatment Revenue Market Size by Application (2018-2023)
Table Global Obesity Treatment Revenue Market Share by Application (2018-2023)
Table Global Obesity Treatment Sales Market Size by Application (2018-2023)
Table Global Obesity Treatment Sales Market Share by Application (2018-2023)
Table Global Obesity Treatment Revenue Market Size by Application (2023-2029)
Table Global Obesity Treatment Revenue Market Share by Application (2023-2029)
Table Global Obesity Treatment Sales Market Size by Application (2023-2029)
Table Global Obesity Treatment Sales Market Share by Application (2023-2029)
Figure Global Obesity Treatment Market Size and Growth by {Application 1} (2018-2029)
Figure Global Obesity Treatment Market Size and Growth by {Application 2} (2018-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans
Table Distributors of Obesity Treatment with Contact Information
Table Major Customers of Obesity Treatment with Contact Information
Table VIVUS Inc. (US) Profile
Table Product Overview
Table VIVUS Inc. (US) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure VIVUS Inc. (US) Sales and Growth Rate
Figure VIVUS Inc. (US) Revenue Market Share 2017-2022
Table Business Overview
Table Arena Pharmaceuticals Inc. (US) Profile
Table Product Overview
Table Arena Pharmaceuticals Inc. (US) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Arena Pharmaceuticals Inc. (US) Sales and Growth Rate
Figure Arena Pharmaceuticals Inc. (US) Revenue Market Share 2017-2022
Table Business Overview
Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd. (Switzerland) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Sales and Growth Rate
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Novo Nordisk A/S (Denmark) Profile
Table Product Overview
Table Novo Nordisk A/S (Denmark) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Novo Nordisk A/S (Denmark) Sales and Growth Rate
Figure Novo Nordisk A/S (Denmark) Revenue Market Share 2017-2022
Table Business Overview
Table Allergan Plc (US) Profile
Table Product Overview
Table Allergan Plc (US) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Allergan Plc (US) Sales and Growth Rate
Figure Allergan Plc (US) Revenue Market Share 2017-2022
Table Business Overview
Table Medtronic (US) Profile
Table Product Overview
Table Medtronic (US) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Medtronic (US) Sales and Growth Rate
Figure Medtronic (US) Revenue Market Share 2017-2022
Table Business Overview
Table Ethicon (a subsidiary of Johnson & Johnson) (US) Profile
Table Product Overview
Table Ethicon (a subsidiary of Johnson & Johnson) (US) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Ethicon (a subsidiary of Johnson & Johnson) (US) Sales and Growth Rate
Figure Ethicon (a subsidiary of Johnson & Johnson) (US) Revenue Market Share 2017-2022
Table Business Overview
Table Cousin Biotech (France) Profile
Table Product Overview
Table Cousin Biotech (France) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Cousin Biotech (France) Sales and Growth Rate
Figure Cousin Biotech (France) Revenue Market Share 2017-2022
Table Business Overview
Table EnteroMedics Inc. (US) Profile
Table Product Overview
Table EnteroMedics Inc. (US) Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure EnteroMedics Inc. (US) Sales and Growth Rate
Figure EnteroMedics Inc. (US) Revenue Market Share 2017-2022
Table Business Overview
Table and USGI Medical Inc. (US). Profile
Table Product Overview
Table and USGI Medical Inc. (US). Obesity Treatment Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure and USGI Medical Inc. (US). Sales and Growth Rate
Figure and USGI Medical Inc. (US). Revenue Market Share 2017-2022
Table Business Overview
Table Research Findings and Conclusion